Over 12 months, Gabelli Healthcare & WellnessRx Trust saw more buying than selling from its insiders — purchases of about $1.2 million against sales of $83,000.
Saba Capital Management, L.P. (10% Owner) made the biggest buy, worth around $244,000.
Last full quarter: net buying by insiders. Insiders bought in 6 of the last 7 full quarters. On the institutional side, 51 funds reported holding GRX at the end of Q2 2026, and more funds sold than bought.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 9, 2026 | Saba Capital Management, L.P. | 10% Owner | Buy | 2,955 | $9.43 | $28K | SEC |
| Oct 8, 2026 | Saba Capital Management, L.P. | 10% Owner | Buy | 4,439 | $9.41 | $42K | SEC |
| Oct 7, 2026 | Saba Capital Management, L.P. | 10% Owner | Buy | 1,775 | $9.38 | $17K | SEC |
| Oct 5, 2026 | Saba Capital Management, L.P. | 10% Owner | Buy | 5,720 | $9.41 | $54K | SEC |
| Oct 5, 2026 | Saba Capital Management, L.P. | 10% Owner | Buy | 500 | $9.35 | $5K | SEC |
| Oct 1, 2026 | Saba Capital Management, L.P. | 10% Owner | Buy | 519 | $9.52 | $5K | SEC |
| Sep 14, 2026 | Saba Capital Management, L.P. | 10% Owner | Buy | 400 | $9.71 | $4K | SEC |
| Sep 8, 2026 | Saba Capital Management, L.P. | 10% Owner | Buy | 500 | $10.08 | $5K | SEC |
| Aug 28, 2026 | Saba Capital Management, L.P. | 10% Owner | Buy | 4,340 | $10.05 | $44K | SEC |
| Aug 24, 2026 | Saba Capital Management, L.P. | 10% Owner | Buy | 7,087 | $10.13 | $72K | SEC |
| Aug 20, 2026 | Saba Capital Management, L.P. | 10% Owner | Buy | 24,102 | $10.13 | $244K | SEC |
| Aug 17, 2026 | Saba Capital Management, L.P. | 10% Owner | Buy | 1,203 | $9.86 | $12K | SEC |
| Aug 13, 2026 | Saba Capital Management, L.P. | 10% Owner | Buy | 200 | $9.93 | $2K | SEC |
| Jan 14, 2026 | GABELLI MARIO J | Director | Buy | 3,800 | $9.58 | $36K | SEC |
| Jan 14, 2026 | GABELLI MARIO J | Director | Buy | 1,010 | $9.58 | $10K | SEC |
In the last 12 months Gabelli Healthcare & WellnessRx Trust insiders made open-market purchases worth about $1.2 million and sales worth about $83,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in GRX was filed on 2026-10-09.
51 investment managers reported holding GRX in SEC Form 13F filings for Q2 2026.
No congressional trades in GRX were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).